Koninklijke Philips N.V. (NYSE: PHG) Stock Competitors & Peer Comparison
See PHG's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHG and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHG | $26.37 | -0.83% | 25.8B | 15.08 | $1.75 | +3.75% |
| ABT | $110.47 | +1.41% | 191.2B | 21.20 | $5.21 | +2.24% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $312.19 | -1.64% | 119.7B | 23.32 | $13.39 | +1.11% |
| MDT | $92.18 | +0.15% | 118B | 16.67 | $5.53 | +3.07% |
| BSX | $48.37 | +0.59% | 71.9B | 15.60 | $3.10 | N/A |
| EW | $90.82 | +0.09% | 52.3B | 33.64 | $2.70 | N/A |
| DXCM | $89.69 | -0.50% | 33.8B | 35.17 | $2.55 | N/A |
| GEHC | $70.56 | +0.20% | 31.9B | 15.47 | $4.56 | +0.20% |
| ZBH | $99.50 | +0.10% | 19.3B | 11.73 | $8.48 | +0.96% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
PHG vs ABT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ABT has a market cap of 191.2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ABT trades at $110.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ABT's P/E ratio is 21.20. In terms of profitability, PHG's ROE is +0.10%, compared to ABT's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
PHG vs BSX-PA Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, PHG's ROE is +0.10%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
PHG vs SYK Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SYK has a market cap of 119.7B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SYK trades at $312.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SYK's P/E ratio is 23.32. In terms of profitability, PHG's ROE is +0.10%, compared to SYK's ROE of +0.16%. Regarding short-term risk, PHG is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SYK's competition here
Medtronic plc (NYSE: MDT)
PHG vs MDT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, MDT has a market cap of 118B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while MDT trades at $92.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas MDT's P/E ratio is 16.67. In terms of profitability, PHG's ROE is +0.10%, compared to MDT's ROE of +0.14%. Regarding short-term risk, PHG is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
PHG vs BSX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BSX has a market cap of 71.9B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BSX trades at $48.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BSX's P/E ratio is 15.60. In terms of profitability, PHG's ROE is +0.10%, compared to BSX's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
PHG vs EW Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, EW has a market cap of 52.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while EW trades at $90.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas EW's P/E ratio is 33.64. In terms of profitability, PHG's ROE is +0.10%, compared to EW's ROE of +0.10%. Regarding short-term risk, PHG is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for PHG.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
PHG vs DXCM Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, DXCM has a market cap of 33.8B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while DXCM trades at $89.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas DXCM's P/E ratio is 35.17. In terms of profitability, PHG's ROE is +0.10%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, PHG is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
PHG vs GEHC Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, GEHC has a market cap of 31.9B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while GEHC trades at $70.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas GEHC's P/E ratio is 15.47. In terms of profitability, PHG's ROE is +0.10%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for PHG.Check GEHC's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
PHG vs ZBH Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ZBH trades at $99.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ZBH's P/E ratio is 11.73. In terms of profitability, PHG's ROE is +0.10%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, PHG is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
PHG vs ABMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ABMD's P/E ratio is 65.36. In terms of profitability, PHG's ROE is +0.10%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, PHG is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
PHG vs PEN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while PEN trades at $322.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas PEN's P/E ratio is 84.30. In terms of profitability, PHG's ROE is +0.10%, compared to PEN's ROE of +0.11%. Regarding short-term risk, PHG is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for PHG.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
PHG vs SWAV Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SWAV's P/E ratio is 78.76. In terms of profitability, PHG's ROE is +0.10%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, PHG is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
PHG vs SNN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SNN has a market cap of 12B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SNN trades at $28.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SNN's P/E ratio is 13.49. In terms of profitability, PHG's ROE is +0.10%, compared to SNN's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
PHG vs ALGN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ALGN trades at $159.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ALGN's P/E ratio is 14.51. In terms of profitability, PHG's ROE is +0.10%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, PHG is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
PHG vs GMED Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, GMED has a market cap of 10.9B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while GMED trades at $80.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas GMED's P/E ratio is 18.17. In terms of profitability, PHG's ROE is +0.10%, compared to GMED's ROE of +0.12%. Regarding short-term risk, PHG is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for PHG.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
PHG vs GKOS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while GKOS trades at $179.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas GKOS's P/E ratio is -208.69. In terms of profitability, PHG's ROE is +0.10%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, PHG is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
PHG vs BIO Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BIO has a market cap of 10.5B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BIO trades at $388.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BIO's P/E ratio is 41.86. In terms of profitability, PHG's ROE is +0.10%, compared to BIO's ROE of +0.03%. Regarding short-term risk, PHG is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
PHG vs BIO-B Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, PHG's ROE is +0.10%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, PHG is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for PHG.Check BIO-B's competition here
Insulet Corp. (NASDAQ: PODD)
PHG vs PODD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, PODD has a market cap of 10.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while PODD trades at $148.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas PODD's P/E ratio is 25.24. In terms of profitability, PHG's ROE is +0.10%, compared to PODD's ROE of +0.27%. Regarding short-term risk, PHG is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
PHG vs MASI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas MASI's P/E ratio is 44.43. In terms of profitability, PHG's ROE is +0.10%, compared to MASI's ROE of +0.09%. Regarding short-term risk, PHG is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for PHG.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
PHG vs BRKR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BRKR has a market cap of 9B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BRKR trades at $59.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BRKR's P/E ratio is 29.66. In terms of profitability, PHG's ROE is +0.10%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, PHG is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
PHG vs BRKRP Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BRKRP has a market cap of 8.7B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BRKRP trades at $435.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BRKRP's P/E ratio is 236.70. In terms of profitability, PHG's ROE is +0.10%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, PHG is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for PHG.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
PHG vs NARI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NARI's P/E ratio is -59.24. In terms of profitability, PHG's ROE is +0.10%, compared to NARI's ROE of -0.00%. Regarding short-term risk, PHG is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for PHG.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
PHG vs HAE Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while HAE trades at $102.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas HAE's P/E ratio is 20.56. In terms of profitability, PHG's ROE is +0.10%, compared to HAE's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for PHG.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
PHG vs LIVN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while LIVN trades at $82.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas LIVN's P/E ratio is 19.57. In terms of profitability, PHG's ROE is +0.10%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
PHG vs ITGR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ITGR trades at $125.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ITGR's P/E ratio is 19.73. In terms of profitability, PHG's ROE is +0.10%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, PHG is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
PHG vs IRTC Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while IRTC trades at $122.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas IRTC's P/E ratio is -284.85. In terms of profitability, PHG's ROE is +0.10%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, PHG is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
PHG vs AXNX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AXNX's P/E ratio is -709.80. In terms of profitability, PHG's ROE is +0.10%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, PHG is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
PHG vs TMDX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while TMDX trades at $84.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas TMDX's P/E ratio is 42.79. In terms of profitability, PHG's ROE is +0.10%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, PHG is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
PHG vs AXGN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AXGN trades at $48.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AXGN's P/E ratio is 127.11. In terms of profitability, PHG's ROE is +0.10%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, PHG is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
PHG vs NEOG Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NEOG trades at $11.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NEOG's P/E ratio is 42.18. In terms of profitability, PHG's ROE is +0.10%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, PHG is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
PHG vs UFPT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while UFPT trades at $292.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas UFPT's P/E ratio is 29.87. In terms of profitability, PHG's ROE is +0.10%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, PHG is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
PHG vs ESTA Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ESTA trades at $74.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ESTA's P/E ratio is -59.46. In terms of profitability, PHG's ROE is +0.10%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, PHG is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
PHG vs NUVA Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NUVA's P/E ratio is 75.00. In terms of profitability, PHG's ROE is +0.10%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, PHG is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
PHG vs NVCR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NVCR trades at $17.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NVCR's P/E ratio is -13.72. In terms of profitability, PHG's ROE is +0.10%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, PHG is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NVCR's competition here
Butterfly Network, Inc. (NYSE: BFLY)
PHG vs BFLY Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BFLY has a market cap of 2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BFLY trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BFLY's P/E ratio is -31.69. In terms of profitability, PHG's ROE is +0.10%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, PHG is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BFLY's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
PHG vs INSP Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while INSP trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas INSP's P/E ratio is 27.80. In terms of profitability, PHG's ROE is +0.10%, compared to INSP's ROE of +0.18%. Regarding short-term risk, PHG is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
PHG vs CNMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CNMD trades at $49.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CNMD's P/E ratio is 10.86. In terms of profitability, PHG's ROE is +0.10%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, PHG is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
PHG vs ATEC Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ATEC trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ATEC's P/E ratio is -153.17. In terms of profitability, PHG's ROE is +0.10%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, PHG is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ATEC's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
PHG vs TNDM Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while TNDM trades at $20.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas TNDM's P/E ratio is -22.11. In terms of profitability, PHG's ROE is +0.10%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, PHG is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
PHG vs HSKA Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas HSKA's P/E ratio is -62.49. In terms of profitability, PHG's ROE is +0.10%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, PHG is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for PHG.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
PHG vs IART Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while IART trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas IART's P/E ratio is 7.12. In terms of profitability, PHG's ROE is +0.10%, compared to IART's ROE of -0.01%. Regarding short-term risk, PHG is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
PHG vs AORT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AORT trades at $26.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AORT's P/E ratio is 43.85. In terms of profitability, PHG's ROE is +0.10%, compared to AORT's ROE of -0.01%. Regarding short-term risk, PHG is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AORT's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
PHG vs PRCT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while PRCT trades at $21.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas PRCT's P/E ratio is -11.32. In terms of profitability, PHG's ROE is +0.10%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, PHG is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
PHG vs AVNS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AVNS's P/E ratio is 27.77. In terms of profitability, PHG's ROE is +0.10%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, PHG is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for PHG.Check AVNS's competition here
Enovis Corporation (NYSE: ENOV)
PHG vs ENOV Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ENOV has a market cap of 1.2B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ENOV trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ENOV's P/E ratio is 5.79. In terms of profitability, PHG's ROE is +0.10%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, PHG is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
PHG vs LMRI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while LMRI trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas LMRI's P/E ratio is -22.86. In terms of profitability, PHG's ROE is +0.10%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, PHG is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
PHG vs SILK Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SILK's P/E ratio is -18.96. In terms of profitability, PHG's ROE is +0.10%, compared to SILK's ROE of -0.35%. Regarding short-term risk, PHG is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
PHG vs IRMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while IRMD trades at $86.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas IRMD's P/E ratio is 43.30. In terms of profitability, PHG's ROE is +0.10%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, PHG is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
PHG vs FNA Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas FNA's P/E ratio is -19.83. In terms of profitability, PHG's ROE is +0.10%, compared to FNA's ROE of -0.35%. Regarding short-term risk, PHG is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for PHG.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
PHG vs BVS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BVS has a market cap of 973.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BVS trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BVS's P/E ratio is 18.91. In terms of profitability, PHG's ROE is +0.10%, compared to BVS's ROE of +0.28%. Regarding short-term risk, PHG is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
PHG vs CBLL Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CBLL has a market cap of 941.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CBLL trades at $24.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CBLL's P/E ratio is -14.10. In terms of profitability, PHG's ROE is +0.10%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, PHG is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
PHG vs BBNX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BBNX has a market cap of 873.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BBNX trades at $19.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BBNX's P/E ratio is -11.77. In terms of profitability, PHG's ROE is +0.10%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, PHG is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
PHG vs INMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, INMD has a market cap of 859.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while INMD trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas INMD's P/E ratio is 10.38. In terms of profitability, PHG's ROE is +0.10%, compared to INMD's ROE of +0.12%. Regarding short-term risk, PHG is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for PHG.Check INMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
PHG vs SIBN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SIBN has a market cap of 849.7M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SIBN trades at $19.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SIBN's P/E ratio is -56.35. In terms of profitability, PHG's ROE is +0.10%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, PHG is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SIBN's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
PHG vs CSII Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CSII's P/E ratio is -20.83. In terms of profitability, PHG's ROE is +0.10%, compared to CSII's ROE of -0.14%. Regarding short-term risk, PHG is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for PHG.Check CSII's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
PHG vs AVR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AVR has a market cap of 835.2M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AVR trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AVR's P/E ratio is -4.43. In terms of profitability, PHG's ROE is +0.10%, compared to AVR's ROE of -0.78%. Regarding short-term risk, PHG is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AVR's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
PHG vs AHCO Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, AHCO has a market cap of 821.8M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while AHCO trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas AHCO's P/E ratio is 12.33. In terms of profitability, PHG's ROE is +0.10%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, PHG is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for PHG.Check AHCO's competition here
Varex Imaging Corporation (NASDAQ: VREX)
PHG vs VREX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas VREX's P/E ratio is 19.44. In terms of profitability, PHG's ROE is +0.10%, compared to VREX's ROE of +0.05%. Regarding short-term risk, PHG is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
PHG vs SSII Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SSII has a market cap of 680.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SSII trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SSII's P/E ratio is -66.32. In terms of profitability, PHG's ROE is +0.10%, compared to SSII's ROE of -0.27%. Regarding short-term risk, PHG is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
PHG vs SRDX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SRDX's P/E ratio is -34.66. In terms of profitability, PHG's ROE is +0.10%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, PHG is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
PHG vs CTKB Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CTKB has a market cap of 605.7M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CTKB trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CTKB's P/E ratio is -24.85. In terms of profitability, PHG's ROE is +0.10%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, PHG is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CTKB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
PHG vs KIDS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, KIDS has a market cap of 585.6M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while KIDS trades at $22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas KIDS's P/E ratio is -19.32. In terms of profitability, PHG's ROE is +0.10%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, PHG is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
PHG vs APEN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas APEN's P/E ratio is -9.43. In terms of profitability, PHG's ROE is +0.10%, compared to APEN's ROE of -0.85%. Regarding short-term risk, PHG is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for PHG.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
PHG vs DCTH Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, DCTH has a market cap of 572.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while DCTH trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas DCTH's P/E ratio is 1658.00. In terms of profitability, PHG's ROE is +0.10%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, PHG is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for PHG.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
PHG vs ZIMV Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, PHG's ROE is +0.10%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, PHG is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
PHG vs CERS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CERS has a market cap of 524M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CERS trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CERS's P/E ratio is -51.90. In terms of profitability, PHG's ROE is +0.10%, compared to CERS's ROE of -0.10%. Regarding short-term risk, PHG is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
PHG vs NPCE Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NPCE has a market cap of 517.9M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NPCE trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NPCE's P/E ratio is -26.65. In terms of profitability, PHG's ROE is +0.10%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, PHG is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for PHG.Check NPCE's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
PHG vs TCMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, TCMD has a market cap of 505.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while TCMD trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas TCMD's P/E ratio is 20.75. In terms of profitability, PHG's ROE is +0.10%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, PHG is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
PHG vs SGHT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SGHT has a market cap of 458.1M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SGHT trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SGHT's P/E ratio is -15.04. In terms of profitability, PHG's ROE is +0.10%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, PHG is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
PHG vs CARL Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CARL has a market cap of 444.2M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CARL trades at $16.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CARL's P/E ratio is -11.43. In terms of profitability, PHG's ROE is +0.10%, compared to CARL's ROE of -0.38%. Regarding short-term risk, PHG is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CARL's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
PHG vs CLPT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CLPT has a market cap of 429.2M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CLPT trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CLPT's P/E ratio is -12.13. In terms of profitability, PHG's ROE is +0.10%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, PHG is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
PHG vs SENS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SENS has a market cap of 415.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SENS trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SENS's P/E ratio is -4.46. In terms of profitability, PHG's ROE is +0.10%, compared to SENS's ROE of -1.66%. Regarding short-term risk, PHG is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check SENS's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
PHG vs PACB Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, PACB has a market cap of 410M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while PACB trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas PACB's P/E ratio is -3.22. In terms of profitability, PHG's ROE is +0.10%, compared to PACB's ROE of -49.62%. Regarding short-term risk, PHG is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PACB's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
PHG vs OFIX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, OFIX has a market cap of 379.2M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while OFIX trades at $9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas OFIX's P/E ratio is -6.11. In terms of profitability, PHG's ROE is +0.10%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, PHG is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
PHG vs CATX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CATX has a market cap of 354.1M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CATX's P/E ratio is -2.33. In terms of profitability, PHG's ROE is +0.10%, compared to CATX's ROE of -0.42%. Regarding short-term risk, PHG is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
PHG vs TLSI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, TLSI has a market cap of 316.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while TLSI trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas TLSI's P/E ratio is -3.06. In terms of profitability, PHG's ROE is +0.10%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, PHG is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TLSI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
PHG vs SMLR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas SMLR's P/E ratio is 3.92. In terms of profitability, PHG's ROE is +0.10%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, PHG is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for PHG.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
PHG vs TMCI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, TMCI has a market cap of 304.9M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while TMCI trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas TMCI's P/E ratio is -5.00. In terms of profitability, PHG's ROE is +0.10%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, PHG is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check TMCI's competition here
CapsoVision, Inc. (NASDAQ: CV)
PHG vs CV Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, CV has a market cap of 296.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while CV trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas CV's P/E ratio is -2.37. In terms of profitability, PHG's ROE is +0.10%, compared to CV's ROE of -1.78%. Regarding short-term risk, PHG is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for PHG.Check CV's competition here
RxSight, Inc. (NASDAQ: RXST)
PHG vs RXST Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, RXST has a market cap of 291M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while RXST trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas RXST's P/E ratio is -6.22. In terms of profitability, PHG's ROE is +0.10%, compared to RXST's ROE of -0.17%. Regarding short-term risk, PHG is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for PHG.Check RXST's competition here
Avita Medical Inc. (NASDAQ: RCEL)
PHG vs RCEL Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, RCEL has a market cap of 267.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while RCEL trades at $10.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas RCEL's P/E ratio is -7.47. In terms of profitability, PHG's ROE is +0.10%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, PHG is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check RCEL's competition here
Profound Medical Corp. (NASDAQ: PROF)
PHG vs PROF Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, PROF has a market cap of 247.8M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while PROF trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas PROF's P/E ratio is -6.96. In terms of profitability, PHG's ROE is +0.10%, compared to PROF's ROE of -0.56%. Regarding short-term risk, PHG is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for PHG.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
PHG vs INFU Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, INFU has a market cap of 245.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while INFU trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas INFU's P/E ratio is 29.66. In terms of profitability, PHG's ROE is +0.10%, compared to INFU's ROE of +0.15%. Regarding short-term risk, PHG is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
PHG vs MGRM Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas MGRM's P/E ratio is -12.00. In terms of profitability, PHG's ROE is +0.10%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, PHG is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for PHG.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
PHG vs ELMD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ELMD has a market cap of 234.6M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ELMD trades at $28.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ELMD's P/E ratio is 21.63. In terms of profitability, PHG's ROE is +0.10%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, PHG is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
PHG vs NVRO Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas NVRO's P/E ratio is -1.91. In terms of profitability, PHG's ROE is +0.10%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, PHG is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for PHG.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
PHG vs STIM Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, STIM has a market cap of 192.8M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while STIM trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas STIM's P/E ratio is -6.30. In terms of profitability, PHG's ROE is +0.10%, compared to STIM's ROE of -1.51%. Regarding short-term risk, PHG is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
PHG vs BSGM Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas BSGM's P/E ratio is -5.81. In terms of profitability, PHG's ROE is +0.10%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, PHG is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for PHG.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
PHG vs LUCD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, LUCD has a market cap of 188.8M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while LUCD trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas LUCD's P/E ratio is -2.68. In terms of profitability, PHG's ROE is +0.10%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, PHG is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
PHG vs MDGS Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas MDGS's P/E ratio is -0.27. In terms of profitability, PHG's ROE is +0.10%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, PHG is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for PHG.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
PHG vs QIPT Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas QIPT's P/E ratio is -15.87. In terms of profitability, PHG's ROE is +0.10%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, PHG is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for PHG.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
PHG vs FOCL Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, FOCL has a market cap of 158.2M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while FOCL trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas FOCL's P/E ratio is -4.08. In terms of profitability, PHG's ROE is +0.10%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, PHG is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for PHG.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
PHG vs QSI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, QSI has a market cap of 150.5M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas QSI's P/E ratio is -1.65. In terms of profitability, PHG's ROE is +0.10%, compared to QSI's ROE of -0.47%. Regarding short-term risk, PHG is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
PHG vs INGN Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, INGN has a market cap of 145.9M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while INGN trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas INGN's P/E ratio is -5.92. In terms of profitability, PHG's ROE is +0.10%, compared to INGN's ROE of -0.13%. Regarding short-term risk, PHG is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for PHG.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
PHG vs QTRX Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, QTRX has a market cap of 122.9M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while QTRX trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas QTRX's P/E ratio is -1.03. In terms of profitability, PHG's ROE is +0.10%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, PHG is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for PHG.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
PHG vs ICAD Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas ICAD's P/E ratio is -20.37. In terms of profitability, PHG's ROE is +0.10%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, PHG is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for PHG.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
PHG vs LNSR Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, LNSR has a market cap of 104.4M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while LNSR trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas LNSR's P/E ratio is 8.67. In terms of profitability, PHG's ROE is +0.10%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, PHG is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for PHG.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
PHG vs HJLI Comparison September 2026
Koninklijke Philips N.V. (NYSE: PHG) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHG stands at 25.8B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, PHG is priced at $26.37 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHG currently has a P/E ratio of 15.08, whereas HJLI's P/E ratio is N/A. In terms of profitability, PHG's ROE is +0.10%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, PHG is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for PHG.Check HJLI's competition here